These miRNAs target particular mRNAs that affect the protein expression involved in BC development, such as the transmembrane glycoprotein cluster of differentiation 44 (CD44), estrogen receptor (ER), progesterone receptor (PR), and receptor tyrosine-protein kinase erbB-2 (HER-2) [96]. Here, ERBB2 is linked to breast cancer.